
Clinical Diagnostics Market by Test (Clinical Diagnostics for Electrolyte Testing, Clinical Diagnostics for Infectious Disease Testing, Complete Blood Count Clinical Diagnostics), Product (Instruments, Reagents), End-User - Global Forecast 2024-2030
Description
Clinical Diagnostics Market by Test (Clinical Diagnostics for Electrolyte Testing, Clinical Diagnostics for Infectious Disease Testing, Complete Blood Count Clinical Diagnostics), Product (Instruments, Reagents), End-User - Global Forecast 2024-2030
The Clinical Diagnostics Market size was estimated at USD 77.80 billion in 2023 and expected to reach USD 84.17 billion in 2024, at a CAGR 8.59% to reach USD 138.53 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Clinical Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Clinical Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMérieux SA, Bioscientia Healthcare GmbH, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Ortho-Clinical Diagnostics, Inc., Quest Diagnostics Inc., Siemens AG, Sonic Healthcare Limited, Sysmex Corporation, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the Clinical Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Test
Clinical Diagnostics for Electrolyte Testing
Clinical Diagnostics for Infectious Disease Testing
Complete Blood Count Clinical Diagnostics
Lipid Panel Clinical Diagnostics
Liver Panel Clinical Diagnostics
Renal Panel Clinical Diagnostics
Product
Instruments
Reagents
End-User
Diagnostic Laboratories
Hospital Laboratories
Point-of-Care Testing
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Clinical Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Clinical Diagnostics Market?
4. What is the market share of the leading vendors in the Clinical Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Clinical Diagnostics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
180 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Clinical Diagnostics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidence of infectious and chronic diseases
- 5.1.1.2. Adoption of automated diagnostic platforms
- 5.1.1.3. Increasing need for genetic test
- 5.1.2. Restraints
- 5.1.2.1. High setup and instruments cost
- 5.1.3. Opportunities
- 5.1.3.1. New developments in clinical diagnostics equipments
- 5.1.3.2. Increasing investment for clinical research
- 5.1.4. Challenges
- 5.1.4.1. Limited skilled laboratory persons
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Clinical Diagnostics Market, by Test
- 6.1. Introduction
- 6.2. Clinical Diagnostics for Electrolyte Testing
- 6.3. Clinical Diagnostics for Infectious Disease Testing
- 6.4. Complete Blood Count Clinical Diagnostics
- 6.5. Lipid Panel Clinical Diagnostics
- 6.6. Liver Panel Clinical Diagnostics
- 6.7. Renal Panel Clinical Diagnostics
- 7. Clinical Diagnostics Market, by Product
- 7.1. Introduction
- 7.2. Instruments
- 7.3. Reagents
- 8. Clinical Diagnostics Market, by End-User
- 8.1. Introduction
- 8.2. Diagnostic Laboratories
- 8.3. Hospital Laboratories
- 8.4. Point-of-Care Testing
- 9. Americas Clinical Diagnostics Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Clinical Diagnostics Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Clinical Diagnostics Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Becton, Dickinson and Company
- 13.1.3. Bio-Rad Laboratories Inc.
- 13.1.4. bioMérieux SA
- 13.1.5. Bioscientia Healthcare GmbH
- 13.1.6. Charles River Laboratories International, Inc.
- 13.1.7. Danaher Corporation
- 13.1.8. F. Hoffmann-La Roche AG
- 13.1.9. Hologic Inc.
- 13.1.10. Ortho-Clinical Diagnostics, Inc.
- 13.1.11. Quest Diagnostics Inc.
- 13.1.12. Siemens AG
- 13.1.13. Sonic Healthcare Limited
- 13.1.14. Sysmex Corporation
- 13.1.15. Thermo Fisher Scientific, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. CLINICAL DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. CLINICAL DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CLINICAL DIAGNOSTICS MARKET DYNAMICS
- FIGURE 7. CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
- FIGURE 8. CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.